AllianceBernstein’s T2 Biosystems, Inc TTOO Stock Holding History

AllianceBernstein’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6	Closed	-$80K	–	3207
2019 Q1	$80K	Sell	6 -1	-14%	-$17K	﹤0.01%	3047
2018 Q4	$99K	Hold	7	–	–	﹤0.01%	2995
2018 Q3	$244K	Buy	7 +1	+17%	+$32.9K	﹤0.01%	2919
2018 Q2	$224K	Buy	+6	New	+$228K	﹤0.01%	2929
2015 Q2	–	Hold	0	–	-$16K	–	3302
2015 Q1	–	Hold	0	–	–	–	3300

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AllianceBernstein's TTOO Position: Q2 2019 in Review

AllianceBernstein sold out of T2 Biosystems, Inc (TTOO) in Q2 2019, closing a stake of 6 shares — an estimated $80K sold.

AllianceBernstein first reported a position in TTOO in Q2 2018 and held it in 4 quarters. The position peaked at $244K in Q3 2018. 63 funds tracked by Wall St. Rank hold TTOO as of Q2 2019.

AllianceBernstein reported no remaining T2 Biosystems, Inc position as of Q2 2019 after selling out during the quarter.
AllianceBernstein sold 6 T2 Biosystems, Inc shares in Q2 2019, an estimated $80K.
AllianceBernstein first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 4 quarters.
AllianceBernstein's T2 Biosystems, Inc position peaked at $244K in Q3 2018.
63 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2019.

Based on AllianceBernstein's 13F filing for Q2 2019, filed 14 Aug 2019.